You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Nature News reports that gene therapy approaches are tackling sickle cell disease, but that the cost of treatment is a concern.
PBS NewsHour reports on initiatives that aim to bolster the representation of minority groups in research.
Novartis has paused a trial of its Zolgensma gene therapy that treats spinal muscular atrophy, the Wall Street Journal reports.
NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.
Direct-to-consumer genetic testing company 23andMe is partnering with clinical trial firm TrialSpark to address low recruitment into clinical trials.
The pilot study with the Mayo Clinic is the final step before SkylineDx commences a US trial next year for its molecular test for primary cutaneous melanoma.
The Guardian writes that UK researchers are concerned that a no-deal Brexit would affect their ability to collaborate on cancer trials in the European Union.
Nature News reports there are a handful of clinical trials underway to evaluate vaginal microbiome seeding of newborns born via caesarian section.
Beyond its HostDx Sepsis test, the firm is working on a test to detect and differentiate bacterial from viral infections in patients presenting with fever.
Doctors in the US have used CRISPR gene editing to try to treat a woman with sickle cell disease as part of a clinical trial, according to Popular Science.
The Chan Zuckerberg Biohub is working with California's health department to sequence viral samples from COVID-19 patients to trace viral introductions, according to the San Francisco Chronicle.
Despite differences in their migration habits, eastern and western monarch butterflies are genetically similar, according to a study in Molecular Ecology.
The UK is implementing COVID-19 testing with a 90-minute turnaround time.
In PLOS this week: identification of fungal species in subcutaneous infections, sequencing of Campylobacter found in raw meat from retail stores, and more.